175 related articles for article (PubMed ID: 19683003)
1. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.
Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M
J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003
[TBL] [Abstract][Full Text] [Related]
2. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
[TBL] [Abstract][Full Text] [Related]
3. DARPins against a functional IgE epitope.
Baumann MJ; Eggel A; Amstutz P; Stadler BM; Vogel M
Immunol Lett; 2010 Oct; 133(2):78-84. PubMed ID: 20673836
[TBL] [Abstract][Full Text] [Related]
4. DARPins: a true alternative to antibodies.
Stumpp MT; Amstutz P
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
[TBL] [Abstract][Full Text] [Related]
6. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
7. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.
Steiner D; Forrer P; Plückthun A
J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916
[TBL] [Abstract][Full Text] [Related]
8. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
[TBL] [Abstract][Full Text] [Related]
9. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
10. DARPins: a new generation of protein therapeutics.
Stumpp MT; Binz HK; Amstutz P
Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567
[TBL] [Abstract][Full Text] [Related]
11. Bispecific designed ankyrin repeat proteins (DARPins) targeting epidermal growth factor receptor inhibit A431 cell proliferation and receptor recycling.
Boersma YL; Chao G; Steiner D; Wittrup KD; Plückthun A
J Biol Chem; 2011 Dec; 286(48):41273-41285. PubMed ID: 21979953
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an in vitro mast cell degranulation test in the context of food allergy to wheat.
Bodinier M; Brossard C; Triballeau S; Morisset M; Guérin-Marchand C; Pineau F; de Coppet P; Moneret-Vautrin DA; Blank U; Denery-Papini S
Int Arch Allergy Immunol; 2008; 146(4):307-20. PubMed ID: 18367844
[TBL] [Abstract][Full Text] [Related]
13. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
[TBL] [Abstract][Full Text] [Related]
14. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
Simon M; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
[TBL] [Abstract][Full Text] [Related]
15. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.
Schilling J; Schöppe J; Plückthun A
J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107
[TBL] [Abstract][Full Text] [Related]
16. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
[TBL] [Abstract][Full Text] [Related]
17. Protection of IgE-mediated allergic sensitization by active immunization with IgE loops constrained in GFP protein scaffold.
Chen SS; Barankiewicz T; Yang YM; Zanetti M; Hill P
J Immunol Methods; 2008 Apr; 333(1-2):10-23. PubMed ID: 18281056
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2.
Jost C; Schilling J; Tamaskovic R; Schwill M; Honegger A; Plückthun A
Structure; 2013 Nov; 21(11):1979-91. PubMed ID: 24095059
[TBL] [Abstract][Full Text] [Related]
19. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha.
Hunter MJ; Vratimos AP; Housden JE; Helm BA
Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193
[TBL] [Abstract][Full Text] [Related]
20. High-affinity binders selected from designed ankyrin repeat protein libraries.
Binz HK; Amstutz P; Kohl A; Stumpp MT; Briand C; Forrer P; Grütter MG; Plückthun A
Nat Biotechnol; 2004 May; 22(5):575-82. PubMed ID: 15097997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
